Supplementary Table S3 from The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

Iseult M. Browne; Javier Pascual; Rosalind J. Cutts; Belinda Kingston; Sarah Hrebien; Lucy Suzanne Kilburn; Alex Pearson; Laura J. Moretti; Andrew M. Wardley; Iain R. Macpherson; Richard D. Baird; Rebecca Roylance; Miguel Gil‐Gil; Ángel L. Guerrero-Zotano; Isaac García-Murillas; Judith M. Bliss; Alistair E. Ring; Miguel Martín; Nicholas C. Turner

doi:10.1158/1078-0432.31006804

Supplementary Table S3 from The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

2026 Open access

Read full text

Authors: Iseult M. Browne, Javier Pascual, Rosalind J. Cutts, Belinda Kingston, Sarah Hrebien, Lucy Suzanne Kilburn, Alex Pearson, Laura J. Moretti, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance

+7 more

Miguel Gil‐Gil, Ángel L. Guerrero-Zotano, Isaac García-Murillas, Judith M. Bliss, Alistair E. Ring, Miguel Martín, Nicholas C. Turner

DOI: 10.1158/1078-0432.31006804

Cited by: 0

Abstract

Baseline characteristics comparison between our ctDNA analysis population and the overall plasmaMATCH population, (A) Cohorts A-D and (B) (Cohort E)

Fields of Study & Subjects

Cancer Genomics and Diagnostics Breast Cancer Treatment Studies BRCA gene mutations in cancer

Publication details

Publication date: 6 January 2026